Yoga as an Add-on Therapy in Parkinson’s Disease: A Single Group Open-label Trial
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2025-01 · 52 (1) · 102-109
DOI: 10.1017/cjn.2024.43 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, online erschienen am 25.03.2024. Verfasst von Pooja Mailankody und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, National Institute of Mental Health & Neuro Sciences, Bangalore, Karnataka, India. Hauptthemen laut MEDLINE: Parkinson Disease, Transcranial Magnetic Stimulation, Yoga. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Objective
We aimed to evaluate the effect of yoga on motor and non-motor symptoms and cortical excitability in patients with Parkinson’s disease (PD).
Methods
We prospectively evaluated 17 patients with PD at baseline, after one month of conventional care, and after one month of supervised yoga sessions. The motor and non-motor symptoms were evaluated using the Unified Parkinson’s disease Rating Scale (motor part III), Hoehn and Yahr stage, Montreal Cognitive Assessment, Hamilton depression rating scale, Hamilton anxiety rating scale, non-motor symptoms questionnaire and World Health Organization quality of life questionnaire. Transcranial magnetic stimulation was used to record resting motor threshold, central motor conduction time, ipsilateral silent period (iSP), contralateral silent period (cSP), short interval intracortical inhibition (SICI), and intracortical facilitation.
Results
The mean age of the patients was 55.5 ± 10.8 years, with a mean duration of illness of 4.0 ± 2.5 years. The postural stability of the patients significantly improved following yoga (0.59 ± 0.5 to 0.18 ± 0.4, p = 0.039). There was a significant reduction in the cSP from baseline (138.07 ± 27.5 ms) to 4 weeks of yoga therapy (116.94 ± 18.2 ms, p = 0.004). In addition, a significant reduction in SICI was observed after four weeks of yoga therapy (0.22 ± 0.10) to (0.46 ± 0.23), p = 0.004).
Conclusion
Yoga intervention can significantly improve postural stability in patients with PD. A significant reduction of cSP and SICI suggests a reduction in GABAergic neurotransmission following yoga therapy that may underlie the improvement observed in postural stability. Clinicaltrialsgov identifier: CTRI/2019/02/017564
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, National Institute of Mental Health & Neuro Sciences, Bangalore, Karnataka, India.
- Department of Biostatistics, National Institute of Mental Health & Neuro Sciences, Bangalore, Karnataka, India.
- Department of Psychiatry, National Institute of Mental Health & Neuro Sciences, Bangalore, Karnataka, India.
ORCID-Profile: Amitabh Bhattacharya, Ravi Yadav, Pramod Kumar Pal
Zitieren
APA
Mailankody, P., Kamble, N., Bhattacharya, A., Shubha Bhat, G. S., Arumugam, T., Thennarasu, K., Arasappa, R., Varambally, S., Yadav, R., & Pal, P. K. (2025). Yoga as an Add-on Therapy in Parkinson’s Disease: A Single Group Open-label Trial. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 52(1), 102-109. https://doi.org/10.1017/cjn.2024.43
Vancouver
Mailankody P, Kamble N, Bhattacharya A, Shubha Bhat GS, Arumugam T, Thennarasu K, et al. Yoga as an Add-on Therapy in Parkinson’s Disease: A Single Group Open-label Trial. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2025;52(1):102-109. doi:10.1017/cjn.2024.43
BibTeX
@article{Mailankody2025,
author = {Mailankody, Pooja and Kamble, Nitish and Bhattacharya, Amitabh and Shubha Bhat, G S and Arumugam, Thamodharan and Thennarasu, K and Arasappa, Rashmi and Varambally, Shivarama and Yadav, Ravi and Pal, Pramod Kumar},
title = {Yoga as an Add-on Therapy in Parkinson’s Disease: A Single Group Open-label Trial},
journal = {Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
year = {2025},
volume = {52},
number = {1},
pages = {102--109},
doi = {10.1017/cjn.2024.43}
}
EUVIMED